Enanta Pharmaceuticals
ENTA
#7459
Rank
ยฃ0.31 B
Marketcap
ยฃ10.68
Share price
0.17%
Change (1 day)
83.69%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -ยฃ57.95 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.32 Million. In 2024 the company made an earning of -ยฃ72.34 Million, an increase over its 2023 earnings that were of -ยฃ95.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ57.95 Million-19.9%
2024 -ยฃ72.34 Million-23.87%
2023 -ยฃ95.02 Million4.39%
2022 -ยฃ91.03 Million-4.4%
2021 -ยฃ95.22 Million91.12%
2020 -ยฃ49.83 Million-407.13%
2019 ยฃ16.22 M-78.63%
2018 ยฃ75.92 M117.97%
2017 ยฃ34.83 M-574.65%
2016 -ยฃ7.34 Million-110.83%
2015 ยฃ67.77 M-4.5%
2014 ยฃ70.96 M-638.53%
2013 -ยฃ13.18 Million-137.98%
2012 ยฃ34.69 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.15 B-42,800.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.19 B-21,653.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ1.23 B-2,288.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.32 B-5,980.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.21 B-30,534.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.99 B-10,688.13%๐Ÿ‡บ๐Ÿ‡ธ USA